Share on Facebook Share on Twitter Email
Answers.com

Lepirudin

 
Drug Info:

Lepirudin

Brand names: Refludan®



Lepirudin Solution for injection

What is this medicine?

LEPIRUDIN is an anticoagulant. It is used in a hospital setting to help prevent blood clots.

This medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions.

What should I tell my health care provider before I take this medicine?

They need to know if you have any of these conditions:
•bleeding disorders or hemophilia
•high blood pressure
•infection of the heart valves
•kidney disease
•liver disease
•lumbar puncture or spinal anesthesia
•recent surgery or trauma
•stomach or intestinal ulcers
•weak or unstable blood vessels
•an unusual or allergic reaction to lepirudin, other medicines, foods, dyes, or preservatives
•pregnant or trying to get pregnant
•breast-feeding

How should I use this medicine?

This medicine is for injection or infusion into a vein. It is given by a health care professional in a hospital or clinic setting.

Talk to your pediatrician regarding the use of this medicine in children. Special care may be needed.

Overdosage: If you think you have taken too much of this medicine contact a poison control center or emergency room at once.
NOTE: This medicine is only for you. Do not share this medicine with others.

What may interact with this medicine?

Do not take this medicine with any of the following medications:
•aspirin and aspirin-like medicines
•medicines that treat or prevent blood clots like warfarin or heparin
•mifepristone

This medicine may also interact with the following medications:
•abciximab
•cilostazol
•clopidogrel
•dipyridamole
•eptifibatide
•lamifiban
•NSAIDs, medicines for pain and inflammation, like ibuprofen or naproxen
•ticlopidine
•tirofiban

This list may not describe all possible interactions. Give your health care provider a list of all the medicines, herbs, non-prescription drugs, or dietary supplements you use. Also tell them if you smoke, drink alcohol, or use illegal drugs. Some items may interact with your medicine.

What should I watch for while using this medicine?

Monitor your skin closely for easy bruising or red spots. Tell your doctor or health care professional if you notice any unusual bruising or bleeding.

Be careful to avoid injury while you are receiving this medicine. Take special care brushing or flossing your teeth. Report any injuries to your doctor or health care professional.

If you are going to have surgery, tell your doctor or health care professional that you have received this medicine.

What side effects may I notice from receiving this medicine?

Side effects that you should report to your doctor or health care professional as soon as possible:
•allergic reactions like skin rash, itching or hives, swelling of the face, lips, or tongue
•back or stomach pain
•black, tarry stools
•blood in urine
•breathing problems
•coughing up blood
•feeling faint or lightheaded, falls
•heavy menstrual bleeding
•nosebleeds
•unusual bleeding or bruising

Side effects that usually do not require medical attention (report to your doctor or health care professional if they continue or are bothersome):
•irritation at site where injected

This list may not describe all possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Where should I keep my medicine?

This drug is given in a hospital or clinic and will not be stored at home.

Last updated: 7/1/2002

Important Disclaimer: The drug information provided here is for educational purposes only. It is intended to supplement, not substitute for, the diagnosis, treatment and advice of a medical professional. This drug information does not cover all possible uses, precautions, side effects and interactions. It should not be construed to indicate that this or any drug is safe for you. Consult your medical professional for guidance before using any prescription or over the counter drugs.

Search unanswered questions...
Enter a question here...
Search: All sources Community Q&A Reference topics

An anticoagulant used for the prevention and treatment of thrombosis and thromboembolism in people who have developed thrombocytopenia with heparin therapy. It is available in a form for intravenous injection or infusion on prescription only.

Side effects:
include bleeding (see anticoagulants), anaemia, fever, and allergic reactions (such as rashes).

Precautions and interactions with other drugs:
lepirudin should not be given to women who are pregnant or breastfeeding and should be used with caution in people with liver or kidney disease and in people who have recently undergone major surgery. The risk of bleeding is increased if lepirudin is used with other anticoagulants, antiplatelet drugs, or fibrinolytic drugs.

Proprietary preparation:
Refludan.

Previous:lenograstim, lenalidomide, leflunomide
Next:lercanidipine, letrozole, leukotriene receptor antagonists
Lepirudin
Systematic (IUPAC) name
[Leu1,Thr2]-63-desulfohirudin
Clinical data
Trade names Refludan
AHFS/Drugs.com monograph
Pregnancy cat. B(US)
Legal status Prescription (US)
Routes SQ or IV
Pharmacokinetic data
Bioavailability 100%
Half-life ~1.3 hours
Excretion Renal
Identifiers
CAS number 120993-53-5 YesY
ATC code B01AE02
DrugBank BTD00024
UNII Y43GF64R34 N
KEGG D03692 YesY
ChEMBL CHEMBL1201666 N
Chemical data
Formula C288H448N80O110S6 
Mol. mass 6983.5 g/mol
 N(what is this?)  (verify)

Lepirudin is an anticoagulant that functions as a direct thrombin inhibitor.

Brand name: Refludan, Generic: Lepirudin rDNA for injection.

Lepirudin is a recombinant hirudin[1] derived from yeast cells. It is almost identical to hirudin extracted from Hirudo medicinalis. It differs by the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63.

Lepirudin may be used as an anticoagulant when heparins (unfractionated or low-molecular-weight) are contraindicated because of heparin-induced thrombocytopenia.

References

  1. ^ Arman T. Askari; A. Michael Lincoff (October 2009). Antithrombotic Drug Therapy in Cardiovascular Disease. Springer. pp. 440–. ISBN 9781603272346. http://books.google.com/books?id=iadLoXoQkWEC&pg=PA440. Retrieved 30 October 2010. 

External links

  • DDB 30082
  • Smythe M, Stephens J, Koerber J, Mattson J (2005). "A comparison of lepirudin and argatroban outcomes.". Clin Appl Thromb Hemost 11 (4): 371–4. doi:10.1177/107602960501100403. PMID 16244762. 
  • Tardy, B; Lecompte, T; Boelhen, F; Tardy-Poncet, B; Elalamy, I; Morange, P; Gruel, Y; Wolf, M et al (2006). "Predictive factors for thrombosis and major bleeding in an observational study in 181 patients with heparin-induced thrombocytopenia treated with lepirudin.". Blood 108 (5): 1492–6. doi:10.1182/blood-2006-02-001057. PMID 16690967. 
  • Lubenow N, Eichler P, Lietz T, Greinacher A (2005). "Lepirudin in patients with heparin-induced thrombocytopenia - results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3.". J Thromb Haemost 3 (11): 2428–36. doi:10.1111/j.1538-7836.2005.01623.x. PMID 16241940. 

 
 
Related topics:
Lepirudin Solution for injection
Drotrecogin Alfa injection
Abciximab Solution for injection

Post a question - any question - to the WikiAnswers community:

 

Copyrights:

Drug Info. Gold Standard. Copyright © 2008 by Gold Standard. All rights reserved.  Read more
 Oxford A-Z of Medicinal Drugs. Market University Press. © 2000, 2003, 2010 An A-Z of Medicinal Drugs. All rights reserved.  Read more
Wikipedia on Answers.com. This article is licensed under the Creative Commons Attribution/Share-Alike License. It uses material from the Wikipedia article Lepirudin Read more

Follow us
Facebook Twitter
YouTube

Mentioned in

» More» More